Asthma Protocol

Respiratory HealthModerate Evidence
7
supplements
2
Primary
5
Supporting
0
Grade A
102
Studies

Primary Stack

Core supplements with strongest evidence
300-400mg daily

Natural bronchodilator that relaxes airway smooth muscle and may reduce airway hyperreactivity

Asthma SymptomsC-Reactive Protein (CRP)
20 studies1,200 participants
1000-4000 IU daily (based on blood levels)

Modulates immune function, reduces airway inflammation, and may decrease exacerbation frequency

Acute Respiratory Tract Infection SymptomsUpper Respiratory Tract Infection RiskAsthma SymptomsEczema SymptomsLung Function
25 studies2,000 participants

Supporting Stack

Additional supplements for enhanced results
10-50 billion CFU daily (Lactobacillus, Bifidobacterium strains)

Modulates gut-lung immune axis; may reduce allergic inflammation and improve immune tolerance

Asthma SymptomsInterleukin 4Lung FunctionImmunoglobulin EImmunoglobulin A
15 studies1,000 participants
2-4g EPA/DHA daily

EPA and DHA reduce inflammatory mediators (leukotrienes) involved in airway inflammation

Airway Inflammation Markers
18 studies1,200 participants
1-2g seeds or 500-1000mg oil daily

Thymoquinone has anti-inflammatory and bronchodilator effects; traditional remedy for respiratory conditions

Allergy SymptomsAsthma SymptomsLung Function
10 studies400 participants
500-1000mg daily

Flavonoid that stabilizes mast cells, inhibits histamine release, and has anti-inflammatory effects

8 studies300 participants
30-100mg daily

Contains crocin and safranal which may reduce airway inflammation and improve lung function

Asthma SymptomsBasophil CountBlood PressureC-Reactive Protein (CRP)Eosinophil count
6 studies250 participants

How This Protocol Works

Simple Explanation

Asthma is a chronic inflammatory disease of the airways characterized by wheezing, shortness of breath, chest tightness, and coughing. It involves airway inflammation, hyperreactivity (overly sensitive airways), and reversible obstruction. While controller medications (inhaled corticosteroids, bronchodilators) are the foundation of treatment, certain supplements may provide additional support for airway health and reduce inflammation.

IMPORTANT: Supplements do not replace asthma medications. Never stop or reduce prescribed medications without consulting your doctor. Have a rescue inhaler available for acute symptoms.

Magnesium acts as a natural bronchodilator—it helps relax the smooth muscle in airways. Intravenous magnesium is actually used in emergency rooms for severe asthma attacks. Oral supplementation may help reduce airway hyperreactivity and improve lung function. Many people with asthma have low magnesium levels, and supplementation may improve symptom control.
Vitamin D deficiency is extremely common in people with asthma and is linked to more frequent exacerbations and worse lung function. Vitamin D modulates immune responses and may reduce airway inflammation. A major Cochrane review found that vitamin D supplementation reduced asthma attacks requiring steroid treatment.
Probiotics work through the gut-lung axis—there's a strong connection between gut microbiome health and respiratory immunity. By supporting healthy gut bacteria, probiotics may help regulate immune responses and reduce allergic inflammation that contributes to asthma.
Fish Oil (Omega-3) contains EPA and DHA which compete with arachidonic acid and reduce production of inflammatory leukotrienes—key mediators in asthma inflammation. While studies show mixed results, omega-3s may be particularly helpful for exercise-induced asthma.
Black Seed (Nigella sativa) has been used traditionally for respiratory conditions. Its active compound thymoquinone has anti-inflammatory and bronchodilator properties. Small clinical trials show improvements in asthma symptoms and lung function.
Quercetin is a plant flavonoid that stabilizes mast cells (preventing histamine release) and has anti-inflammatory effects. It may help reduce allergic responses that trigger asthma symptoms.
Saffron contains compounds with anti-inflammatory properties that may benefit airway inflammation. Early clinical trials show promise for improving lung function and reducing symptoms.

Expected timeline: Magnesium: 1-2 weeks. Vitamin D: 2-3 months (based on correcting deficiency). Probiotics: 4-8 weeks. Omega-3: 6-12 weeks for anti-inflammatory effects. Black seed/saffron: 4-8 weeks.

Clinical Perspective

Asthma involves chronic airway inflammation (eosinophilic, neutrophilic, or mixed), airway hyperresponsiveness, mucus hypersecretion, and airway remodeling. Pathophysiology includes Th2-mediated inflammation (IL-4, IL-5, IL-13), mast cell activation, IgE production, and leukotriene synthesis. This protocol targets inflammation modulation and bronchodilation as adjuncts to standard pharmacotherapy.

CRITICAL: Supplements are adjunctive only. Maintain inhaled corticosteroids and rescue medications per asthma action plan. Monitor peak flow and symptoms closely.

Magnesium (B-grade): Inhibits calcium channels, causing smooth muscle relaxation. Reduces acetylcholine release and histamine from mast cells. IV magnesium is established treatment for acute severe asthma. Systematic review: oral supplementation may improve FEV1 and symptom control, particularly in deficient individuals (PMID: 29981570). Dietary magnesium inversely associated with asthma severity (PMID: 30618140). 300-400mg/day; check serum magnesium.
Vitamin D (B-grade): Regulates innate and adaptive immunity. Enhances antimicrobial peptides (cathelicidin), modulates Th1/Th2 balance, supports regulatory T cells. Deficiency highly prevalent in asthma and correlates with worse outcomes. Cochrane review: supplementation reduced exacerbations requiring systemic corticosteroids (OR 0.63) and emergency visits (PMID: 28202713). Further trials confirm benefit for exacerbation reduction (PMID: 30773823). Target 25(OH)D >30 ng/mL; doses 1000-4000 IU/day based on baseline.
Probiotics (B-grade): Gut-lung axis modulation. Influence dendritic cell function, enhance regulatory T cells, reduce Th2 cytokines. Systematic review: potential benefit for symptom control and quality of life, though heterogeneity in strains studied (PMID: 26343052). Lactobacillus and Bifidobacterium most studied. 10-50 billion CFU/day. May be more beneficial for allergic asthma.
Fish Oil (Omega-3) (C-grade): EPA competitively inhibits arachidonic acid conversion to 4-series leukotrienes (potent bronchoconstrictors). Produces less inflammatory 5-series leukotrienes. Systematic review: modest improvements in some outcomes, inconsistent results (PMID: 28915435). May benefit exercise-induced bronchoconstriction. 2-4g EPA/DHA daily.
Black Seed (Nigella sativa) (C-grade): Thymoquinone inhibits 5-lipoxygenase and cyclooxygenase, reduces oxidative stress, has smooth muscle relaxant properties. Review of clinical trials: improvements in lung function parameters (FEV1, PEFR) and symptom scores (PMID: 29438914). 1-2g seeds or equivalent oil. Traditional use supports safety.
Quercetin (C-grade): Flavonoid that inhibits protein kinase C and histamine release from mast cells. Modulates NF-κB and reduces cytokine production. Review: theoretical benefit supported by in vitro and animal data; limited clinical trials in asthma (PMID: 27187333). 500-1000mg/day. Poor bioavailability improved with bromelain.
Saffron (Crocus sativus) (B-grade): Crocin and safranal have anti-inflammatory effects, inhibit histamine H1 receptors, and relax smooth muscle. Clinical trial: improved FEV1 and reduced asthma symptoms (PMID: 31422467). Emerging evidence. 30-100mg/day of saffron extract.

Biomarker targets: Peak expiratory flow (PEF), spirometry (FEV1, FEV1/FVC), FeNO (fractional exhaled nitric oxide), symptom scores (ACT, ACQ), exacerbation frequency, serum 25(OH)D, serum magnesium, IgE levels.

Protocol notes: Allergen avoidance and trigger identification are foundational. Address GERD (can worsen asthma). Weight loss improves asthma control in obesity. Regular physical activity (with proper warm-up) is beneficial despite exercise-induced symptoms. Avoid beta-blockers and NSAIDs if sensitive. Monitor for aspirin-exacerbated respiratory disease (AERD). Consider allergy immunotherapy for allergic triggers. Smoking cessation is critical. Influenza and pneumococcal vaccines recommended. Occupational asthma requires exposure elimination. Severe asthma may benefit from biologics (omalizumab, mepolizumab, dupilumab).